CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
Year: 2022
Type: review
Authors: Jiachen Wen, Siyuan Wang, Rongxian Guo, Dan Liu
Institutions: Shenyang Pharmaceutical University, Yangzhou University
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: CSF1R inhibitor, colony-stimulating factor 1 receptor, tumor-associated macrophages, receptor tyrosine kinase, tumor microenvironment, small molecule inhibitors, PLX3397, pexidartinib, tenosynovial giant cell tumor, combination therapy, osteoclasts, PI3K signaling, ERK signaling, JNK signaling
Open Access status: closed
OpenAlex ID: W4308346200
